Make Better Decisions - Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

Get the Book: Make Better Decisions

Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

PDF eBook: Just $10 Get Print Book on Amazon

Serving leading biopharmaceutical companies globally:

Harvard Business School
Boehringer Ingelheim
Medtronic
Mallinckrodt
Merck
Johnson and Johnson

Last Updated: November 18, 2019

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 020715

See Plans and Pricing

« Back to Dashboard

NDA 020715 describes TRELSTAR, which is a drug marketed by Allergan Sales Llc and is included in three NDAs. It is available from one supplier. There is one patent protecting this drug. Additional details are available on the TRELSTAR profile page.

The generic ingredient in TRELSTAR is triptorelin pamoate. There are three drug master file entries for this compound. Two suppliers are listed for this compound. Additional details are available on the triptorelin pamoate profile page.
Summary for 020715
Tradename:TRELSTAR
Applicant:Allergan Sales Llc
Ingredient:triptorelin pamoate
Patents:0
Medical Subject Heading (MeSH) Categories for 020715
Suppliers and Packaging for NDA: 020715
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
TRELSTAR triptorelin pamoate INJECTABLE;INTRAMUSCULAR 020715 NDA Allergan, Inc. 0023-5902 0023-5902-04 1 KIT in 1 CARTON (0023-5902-04) * 2 mL in 1 VIAL, SINGLE-DOSE * 2 mL in 1 SYRINGE

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:INJECTABLE;INTRAMUSCULARStrengthEQ 3.75MG BASE/VIAL
Approval Date:Jun 15, 2000TE:RLD:Yes

Expired US Patents for NDA 020715

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Allergan Sales Llc TRELSTAR triptorelin pamoate INJECTABLE;INTRAMUSCULAR 020715-001 Jun 15, 2000   Start Trial   Start Trial
Allergan Sales Llc TRELSTAR triptorelin pamoate INJECTABLE;INTRAMUSCULAR 020715-001 Jun 15, 2000   Start Trial   Start Trial
Allergan Sales Llc TRELSTAR triptorelin pamoate INJECTABLE;INTRAMUSCULAR 020715-001 Jun 15, 2000   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration

Complete Access Available with Subscription

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Express Scripts
Mallinckrodt
Merck
Baxter
McKinsey
Colorcon

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.